TPX2 and neoplasm: The expression of AURKA-B, TPX-2, MDR, Scr, and survivin by immunohistochemistry (IHC) and amplification of FGFR1 by fluorescence in situ hybridization (FISH) on tumor biopsies was also evaluated.